Search General Info
Search Education
Search Partnering Companies

Ksenija Pavletic Aranicki, MBA, MSc

Geneva, Switzerland
Mrs. Pavletic Aranicki is PregLem’s Chief Executive Officer. She has 20 years of experience in the pharmaceutical industry in both large pharma companies as well as start-up biotech. Mrs. Pavletic Aranicki’s skills are in pharmaceutical marketing, commercial operations, business development activities (licensing deals), and raising money via public and private financings. She joined PregLem in 2008 from Merck Serono where she was Global Marketing Director – Reproductive Health. As a VP of Business Development and later Chief Commercial Officer in PregLem she was a member of the management team that lead the company to the successful European registration of Esmya®, and subsequently its launch in EU. The company was acquired by Gedeon Richter Plc. in 2010.

Mrs. Pavletic holds an MSc in Biotechnology from Zagreb University (Croatia) and an MBA from Webster University in Geneva (Switzerland).
Speaking In
[Available On-Demand]
The latest UN estimates show men slightly outnumber women globally, but the future of biopharma is…